178 related articles for article (PubMed ID: 1400315)
41. Metabolism of platelet-activating factor in human haematopoietic cell lines. Differences between myeloid and lymphoid cells.
Garcia MC; Garcia C; Gijon MA; Fernandez-Gallardo S; Mollinedo F; Sanchez Crespo M
Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):573-8. PubMed ID: 1847616
[TBL] [Abstract][Full Text] [Related]
42. Metabolic conversion of platelet-activating factor into ethanolamine plasmalogen in an amnion-derived cell line.
Frenkel RA; Johnston JM
J Biol Chem; 1992 Sep; 267(27):19186-91. PubMed ID: 1527040
[TBL] [Abstract][Full Text] [Related]
43. Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor.
Triggiani M; Connell TR; Chilton FH
J Immunol; 1990 Oct; 145(7):2241-8. PubMed ID: 2118931
[TBL] [Abstract][Full Text] [Related]
44. MgATP has different inhibitory effects on the use of 1-acyl-lysophosphatidylcholine and lyso platelet-activating factor acceptors by neuronal nuclear acetyltransferase activities.
Baker RR; Chang H
Biochim Biophys Acta; 1998 Jun; 1392(2-3):351-60. PubMed ID: 9630721
[TBL] [Abstract][Full Text] [Related]
45. Subcellular localization of phospholipids and enzymes involved in PAF-acether metabolism.
Record M; Ribbes G; Tercé F; Chap H
J Cell Biochem; 1989 Jul; 40(3):353-9. PubMed ID: 2506197
[TBL] [Abstract][Full Text] [Related]
46. Synthesis of 1-acyl-2-[3H]acetyl-SN-glycero-3-phosphocholine, a structural analog of platelet activating factor, by vascular endothelial cells.
Mueller HW; Nollert MU; Eskin SG
Biochem Biophys Res Commun; 1991 May; 176(3):1557-64. PubMed ID: 2039529
[TBL] [Abstract][Full Text] [Related]
47. Release of arachidonic acid from 1-alkyl-2-acyl-sn-glycero-3-phosphocholine, a precursor of platelet-activating factor, in rat alveolar macrophages.
Albert DH; Snyder F
Biochim Biophys Acta; 1984 Oct; 796(1):92-101. PubMed ID: 6435681
[TBL] [Abstract][Full Text] [Related]
48. Bioactive amide of prostaglandin E1 and ethanolamine plasmalogen analog of platelet-activating factor inhibits several pathways of human platelet aggregation.
Kulikov VI; Muzya GI
Biochemistry (Mosc); 2000 Apr; 65(4):427-30. PubMed ID: 10810178
[TBL] [Abstract][Full Text] [Related]
49. Outer-membrane porins from gram-negative bacteria stimulate platelet-activating-factor biosynthesis by cultured human endothelial cells.
Tufano MA; Biancone L; Rossano F; Capasso C; Baroni A; De Martino A; Iorio EL; Silvestro L; Camussi G
Eur J Biochem; 1993 Jun; 214(3):685-93. PubMed ID: 8391435
[TBL] [Abstract][Full Text] [Related]
50. Acetylation of sphingosine by PAF-dependent transacetylase.
Lee T
Adv Exp Med Biol; 1996; 416():113-9. PubMed ID: 9131136
[TBL] [Abstract][Full Text] [Related]
51. Influence of isoproterenol and phosphodiesterase inhibitors on platelet-activating factor biosynthesis in the human neutrophil.
Fonteh AN; Winkler JD; Torphy TJ; Heravi J; Undem BJ; Chilton FH
J Immunol; 1993 Jul; 151(1):339-50. PubMed ID: 8392098
[TBL] [Abstract][Full Text] [Related]
52. Identification of a lysophospholipase C that may be responsible for the biosynthesis of choline plasmalogens by Madin-Darby canine kidney cells.
Strum JC; Daniel LW
J Biol Chem; 1993 Dec; 268(34):25500-8. PubMed ID: 8244986
[TBL] [Abstract][Full Text] [Related]
53. Formation of 1-alkyl-2-acetyl-sn-glycerols via the de novo biosynthetic pathway for platelet-activating factor. Characterization of 1-alkyl-2-acetyl-sn-glycero-3-phosphate phosphohydrolase in rat spleens.
Lee TC; Malone B; Snyder F
J Biol Chem; 1988 Feb; 263(4):1755-60. PubMed ID: 2828351
[TBL] [Abstract][Full Text] [Related]
54. Conversion of alkylacetylglycerol to platelet-activating factor in HL-60 cells and subcellular localization of the mediator.
Vallari DS; Record M; Snyder F
Arch Biochem Biophys; 1990 Feb; 276(2):538-45. PubMed ID: 2154953
[TBL] [Abstract][Full Text] [Related]
55. Biosynthesis of platelet-activating factor (PAF) in human polymorphonuclear leucocytes. The role of lyso-PAF disposal and free arachidonic acid.
Garcia MC; Fernandez-Gallardo S; Gijon MA; Garcia C; Nieto ML; Sanchez Crespo M
Biochem J; 1990 May; 268(1):91-8. PubMed ID: 1693077
[TBL] [Abstract][Full Text] [Related]
56. Human endothelial cells are target for platelet-activating factor. II. Platelet-activating factor induces platelet-activating factor synthesis in human umbilical vein endothelial cells.
Heller R; Bussolino F; Ghigo D; Garbarino G; Pescarmona G; Till U; Bosia A
J Immunol; 1992 Dec; 149(11):3682-8. PubMed ID: 1431139
[TBL] [Abstract][Full Text] [Related]
57. The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets.
Touqui L; Shaw AM; Dumarey C; Jacquemin C; Vargaftig BB
Biochem J; 1987 Jan; 241(2):555-60. PubMed ID: 3109377
[TBL] [Abstract][Full Text] [Related]
58. Evidence for different mechanisms involved in the formation of lyso platelet-activating factor and the calcium-dependent release of arachidonic acid from human neutrophils.
Winkler JD; Sung CM; Hubbard WC; Chilton FH
Biochem Pharmacol; 1992 Nov; 44(10):2055-66. PubMed ID: 1449523
[TBL] [Abstract][Full Text] [Related]
59. Characterization of the enzymatic hydrolysis of acetate from alkylacetylglycerols in the de novo pathway of PAF biosynthesis.
Blank ML; Smith ZL; Cress EA; Snyder F
Biochim Biophys Acta; 1990 Feb; 1042(2):153-8. PubMed ID: 2302414
[TBL] [Abstract][Full Text] [Related]
60. Catabolism of platelet-activating factor by human colonic mucosa. Calcium dependence of the catabolizing enzymes.
Appleyard CB; Hillier K
Biochem Pharmacol; 1992 Jun; 43(12):2503-9. PubMed ID: 1632809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
